Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer

Oncology

Volumn 55, Issue 6, 1998, Pages 594-599

  Maeda, Kiyoshi ^a   Kang, Soon Myoung ^a   Onoda, Naoyoshi ^a   Ogawa, Masafumi ^a   Sawada, Tetsuji ^a   Nakata, Bunzo ^a   Kato, Yasuyuki ^a   Chung, Yong Suk ^a   Sowa, Michio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; p53; Tumor angiogenesis; Vascular endothelial growth factor

Indexed keywords

PROTEIN P53; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VASCULARIZATION;

ADULT; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031725558     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000011918     Document Type: Article

References (23)

1. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84: 1875-1887.
3. Gasparini G, Weidner N, Bevilacqua P, Maulta S, Palma PD, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic marker in node-negative breast carcinoma. J Clin Oncol 1994;12:454-466.
4. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y, Kondo Y, Sowa M: Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995;13:477-481.
5. Bicknell R, Harris AL: Novel growth regulatory factors and tumor angiogenesis. Eur J Cancer 1991;27:781-784.
6. Dvorak HF, Siossat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van De Water L, Senger DR: Distribution of vascular permeability factors in tumors: Concentration in tumor blood vessels. J Exp Med 1991;174:1275-1278.
7. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T, Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-863.
8. Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 1992;70:523-526.
9. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994;266:1821-1828.
10. Kieser A, Weich HA, Brander G, Marmé D, Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994;9: 963-969.
11. Mukhopadyay D, Tsiokas L, Sukhatme VP: Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995;55: 6161-6165.
12. Japanese Research Society for Gastric Cancer: The General Rules for Gastric Cancer Study. Jpn J Surg 1981;11:127-139.
13. Van Den Berg FM, Tigges A, Schipper M, Den Hartog-Jager FCA, Kroes WGM, Walboomers JMM: Expression of the nuclear oncogene p53 in colon tumors. J Pathol 1989;157:193-199.
14. Maeda K, Ogawa M, Chung YS, Kang SM, Sawada T, Onoda N, Nakata B, Kato Y, Sowa M: Overexpression of p53 associated with tumor angiogenesis, tumor cell proliferation, and prognosis in gastric carcinoma. Oncol Rep 1997;4:765-768.
15. Martin H, Filipe M, Morris R, Lane D, Silvestre F: p53 expression and prognosis in gastric carcinoma. Int J Cancer 1993;50:859-862.
16. Starzynska T, Bromley M, Ghosh A, Stern PL: Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992;66:558-562.
17. Fonseca L, Yonemura Y, De Aretxabala X, Yamaguchi A, Miwa K, Miyazaki I: p53 detection as a prognostic factor in early gastric cancer. Oncology 1994;51:485-490.
18. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84:1470-1478.
19. Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast carcinoma. Jpn J Cancer Res 1994;85:1045-1049.
20. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1996; 55:3964-3968.
21. Fontanini G, Vignati S, Lucchi M, Mussi A, Calcinai A, Boldrini L, Chine S, Silvestri V, Angeletti CA, Basolo F, Bevilacqua G: Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor expression. Br J Cancer 1997;75:1295-1301.
22. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, Ueshima H: Clinico-pathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 1994; 58:14-19.
23. Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowitcz E, Guillem JG, Cordon-Cardo C, Cohen AM: p53 overexpression: An independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 1994;12:2043-2050.